Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 10Recruiting 10Completed 8Terminated 7Active not recruiting 5Not yet recruiting 4Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 3Neoplasms 3Leukemia, Myeloid, Acute 3Breast Neoplasms 3Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Myeloid 1Rectal Neoplasms 1Pruritus 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Pancreatic Adenocarcinoma 1Overweight 1Oropharyngeal Neoplasms 1Opioid-Related Disorders 1Obesity 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1Liver Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Carboplatin 33Pemetrexed 25Cisplatin 23Paclitaxel 20Radiotherapy 16Docetaxel 16Gemcitabine 15durvalumab 14Radiosurgery 14pembrolizumab 13Nivolumab 13Erlotinib Hydrochloride 10Taxes 8atezolizumab 7Magnetic Resonance Spectroscopy 7Drug Therapy 6Cyclophosphamide 6Bevacizumab 6Platinum 5Gefitinib 5130-nm albumin-bound paclitaxel 5Etoposide 4Biopsy 4Albumin-Bound Paclitaxel 41,2-diaminocyclohexaneplatinum II citrate 4spartalizumab 3sotorasib 3poly ICLC 3capmatinib 3Surveys and Questionnaires 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Non-Small-Cell Lung × Blood Specimen Collection × Clear all
NCT02705339 2016-05-17

Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)

Washington University School of Medicine

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡